Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1973 Oct;28(4):316–321. doi: 10.1038/bjc.1973.154

The Inhibition by Aspirin and Indomethacin of Osteolytic Tumour Deposits and Hypercalcaemia in Rats with Walker Tumour, and its Possible Application to Human Breast Cancer

T J Powles, S A Clark, D M Easty, G C Easty, A Munro Neville
PMCID: PMC2008894  PMID: 4759939

Abstract

Walker carcinosarcoma cells cause in vitro osteolysis which may be inhibited by aspirin. In the rat, this tumour produces osteolytic bone deposits and hypercalcaemia, both of which can be prevented by aspirin and indomethacin, whereas soft tissue tumour deposits are unaffected by these drugs. Some human breast tumours cause in vitro osteolysis which may be inhibited by aspirin.

Full text

PDF
321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Galasko C. S., Burn J. I. Hypercalcaemia in patients with advanced mammary cancer. Br Med J. 1971 Sep 4;3(5774):573–577. doi: 10.1136/bmj.3.5774.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gullino P. M., Grantham F. H., Smith S. H., Haggerty A. C. Modifications of the acid-base status of the internal milieu of tumors. J Natl Cancer Inst. 1965 Jun;34(6):857–869. [PubMed] [Google Scholar]
  3. Klein D. C., Raisz L. G. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 1970 Jun;86(6):1436–1440. doi: 10.1210/endo-86-6-1436. [DOI] [PubMed] [Google Scholar]
  4. Miller W. S., Smith J. G., Jr Effect of acetylsalicylic acid on lysosomes. Proc Soc Exp Biol Med. 1966 Jul;122(3):634–636. doi: 10.3181/00379727-122-31212. [DOI] [PubMed] [Google Scholar]
  5. Poole A. R. Invasion of cartilage by an experimental rat tumor. Cancer Res. 1970 Aug;30(8):2252–2259. [PubMed] [Google Scholar]
  6. Reynolds J. J. Inhibition by calcitonin of bone resorption induced in vitro by vitamin A. Proc R Soc Lond B Biol Sci. 1968 May 14;170(1018):61–69. doi: 10.1098/rspb.1968.0024. [DOI] [PubMed] [Google Scholar]
  7. Tashjian A. H., Jr, Voelkel E. F., Levine L., Goldhaber P. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer. J Exp Med. 1972 Dec 1;136(6):1329–1343. doi: 10.1084/jem.136.6.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES